ORMD-0801 (qd)
ORA-D-012
Phase 3 small_molecule completed
Quick answer
ORMD-0801 (qd) for Type 2 Diabetes Mellitus is a Phase 3 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ORAMED PHARMACEUTICALS INC.
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed